EUVIMEDEUVIMED entdecken
Crossref

Synthesis, crystal structure, Hirshfeld surface, computational and biological studies of spiro-oxindole derivatives as MDM2-p53 inhibitors

Monisha Sivanandhan, Sutha Ragupathy, Arumugam Thangamani, Amutha Parasuraman

Molecular Diversity · 2025

DOI: 10.1007/s11030-024-10974-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Diversity, 2025. Verfasst von Monisha Sivanandhan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, PSGR Krishnammal College for Women, Coimbatore, 641004, Tamil Nadu, India. Hauptthemen laut MEDLINE: Oxindoles, Proto-Oncogene Proteins c-mdm2, Spiro Compounds, Tumor Suppressor Protein p53. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 74 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The spiro-oxindole derivatives were synthesized via a 1,3-dipolar cycloaddition approach and characterized by FT-IR, 1H, 13C NMR and mass spectral techniques. The single crystal XRD of 6d further validates the formation of compounds. DFT calculations indicated the reactive nature of compound 6d. Docking studies with 5LAW disclosed the minimum binding energy of - 10.83 kcal/mol for 6d. Furthermore, safe oral bioavailability was ensured by the physicochemical, pharmacokinetic, and toxicity predictions. The anticancer analysis of synthesized compounds showed substantial activity against A549 cells, notably with an IC50 value of 8.13 ± 0.66 µM for 6d compared to standard doxorubicin. 6d was also evaluated for cytotoxicity against L929 healthy cells and A549, showing selectivity towards A549 than healthy cells. AO/EB staining method showed early apoptotic cellular death in the A549 cell line in a dose-dependent manner.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OxindolesProto-Oncogene Proteins c-mdm2Spiro CompoundsTumor Suppressor Protein p53Antineoplastic AgentsHumansMolecular Docking SimulationCrystallography, X-RayStructure-Activity RelationshipA549 CellsCell Line, TumorApoptosisMolecular Structure

Stichwörter der Autor:innen

ADMETApoptosisDFTDockingHirshfeld surface analysisMDM2-p53 inhibitorSingle crystal XRD

Substanzen

OxindolesProto-Oncogene Proteins c-mdm2Spiro CompoundsTumor Suppressor Protein p53Antineoplastic AgentsMDM2 protein, human2-oxindole

Autor:innen und Institutionen

  • Department of Chemistry, PSGR Krishnammal College for Women, Coimbatore, 641004, Tamil Nadu, India.
  • Department of Chemistry, Karpagam Academy of Higher Education, Coimbatore, 641021, Tamil Nadu, India.
  • Department of Chemistry, PSGR Krishnammal College for Women, Coimbatore, 641004, Tamil Nadu, India. amuchem@gmail.com.

Zitieren

APA

Sivanandhan, M., Ragupathy, S., Thangamani, A., & Parasuraman, A. (2025). Synthesis, crystal structure, Hirshfeld surface, computational and biological studies of spiro-oxindole derivatives as MDM2-p53 inhibitors. Molecular Diversity. https://doi.org/10.1007/s11030-024-10974-x

Vancouver

Sivanandhan M, Ragupathy S, Thangamani A, Parasuraman A. Synthesis, crystal structure, Hirshfeld surface, computational and biological studies of spiro-oxindole derivatives as MDM2-p53 inhibitors. Molecular Diversity. 2025. doi:10.1007/s11030-024-10974-x

BibTeX
@article{Sivanandhan2025,
  author = {Sivanandhan, Monisha and Ragupathy, Sutha and Thangamani, Arumugam and Parasuraman, Amutha},
  title = {Synthesis, crystal structure, Hirshfeld surface, computational and biological studies of spiro-oxindole derivatives as MDM2-p53 inhibitors},
  journal = {Molecular Diversity},
  year = {2025},
  doi = {10.1007/s11030-024-10974-x}
}
Kostenlos starten →